In Vitro Diagnostics And IVD Quality Control Industry Data Book | Forecast 2030
In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 – 2030
Grand View Research’s In Vitro Diagnostics and IVD quality control industry data book is a collection of market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, volumetric analyses, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the database, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.
Access the Global In Vitro Diagnostics And IVD Quality Control Industry Data Book, 2022 to 2030, compiled with details like market sizing & forecasts insights, regulatory & technology framework, pricing intelligence, volumetric analyses, competitive benchmarking analyses, macro-environmental analyses studies.
In Vitro Diagnostics Market Report Highlights
The global in vitro diagnostics market size is expected to reach USD 106.16 billion by 2030, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of -2.8% over the forecast period.
- Molecular diagnostics is anticipated to grow at the fastest CAGR from 2023 to 2030 owing to the rising adoption and usage rate
- Reagents held the largest market share owing to the surge in demand for genetic testing and enhanced availability of technologically advanced diagnostic tests in lower and middle-income countries with unmet clinical needs
- The infectious diseases application segment held the largest market share owing to the large volume of testing for infectious diseases globally
- North America dominated the global market in 2022 owing to the high demand for novel technologies, a large pool of key players, high prevalence of diseases, and advanced healthcare infrastructure
IVD Quality Control Market Report Highlights
The global IVD quality control market size is expected to reach USD 1.24 billion by 2026, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 4.1% over the forecast period.
- In 2018, the clinical chemistry was the second-largest application segment of the global IVD market, in terms of market share
- Demand for preventive medicine and rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors for the segment’s growth
- Molecular diagnostics is projected to be the fastest-growing segment due to increasing technical complexity of molecular diagnostic testing and need for quality evaluation to ensure standards
- These tests are of prime importance as the outcomes enable healthcare practitioners make critical treatment decisions
- Hospitals was the largest segment in 2018 due to the presence of advanced technology-based devices like Next Generation Sequencing (NGS) and microarrays, and rising applications of the optimized quality-control procedures
- North America was the dominant regional market in 2018 due to the presence of over 150,000 registered diagnostics labs and is likely to maintain the dominance throughout the forecast years
Order your copy of the Free Sample of “In Vitro Diagnostics And IVD Quality Control Industry Data Book - In Vitro Diagnostics & IVD Quality Control Market Size, Share, Trends Analysis, And Segment Forecasts, 2022 – 2030” Data Book, published by Grand View Research
Competitive Landscape
Key players operating in the In Vitro Diagnostics And IVD Quality Control industry are
- ABBOTT
- BIOMÉRIEUX SA
- BIO-RAD LABORATORIES, INC.
- BECTON, DICKINSON AND COMPANY
- SIEMENS HEALTHINEERS AG
- QIAGEN
- QUIDEL CORPORATION
- HOFFMANN-LA ROCHE LTD.
- SYSMEX CORPORATION
- CHARLES RIVER LABORATORIES
Grand View Research’s In Vitro Diagnostics And IVD Quality Control Industry data book is a collection of market sizing information & forecasts, regulatory data, reimbursement structure, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, all such information is systematically analyzed and provided in the form of presentations and detailed outlook reports on individual areas of research.
Check out more Industry Data Books, published by Grand View Research
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sampleThe regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
The QC schemes are appropriate to plasma-based, whole blood-based and serum-based products.
In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testingApplication InsightsThere are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology.
11 February 2020 - The global In Vitro Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13 billion by 2024.
The rising number of certified clinical laboratories requires quality control (QC) services to maintain their standards, associated with the increasing acceptance of third party providers of quality control services, to ensure the accurate and reproducible test results, and better outcomes which is anticipated to drive the growth.For the establishment of definite standards of quality, the internal Quality Control (QC) programs and the external QAS (Quality Assurance Schemes) is very important to ensure validity and reliability of the test results obtained by the IVD devices.
These programs are essential in confirming the delivery of patient diagnostic outcomes, which are reliable and without errors, such as misdiagnosis because of device-related errors, which can impact the health of the patient.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-marketThe regulation of these In vitro diagnostics devices are controlled by the respective regulatory bodies, which includes the U.S. FDA (Food and Drug Administration), the International Medical Device Regulators Forum (IMDRF), the European Commission, the Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union (EEU) and the Brazilian National Health Surveillance Agency (ANVISA).The currently undergoing, extensive R related activities beside the introduction of new laws with the aim of improving the efficacy and safety levels of the IVD services are anticipated to drive market growth.
For example, in September 2012, a new regulation for IVD devices was published by the European Commission targeted to enhance the transparency, safety and the traceability without constraining innovation.
In 2016, QC market was one of the largest segments because of the rapidly developing IVD technologies and the existence of numerous internal QC programs for the different features of the IVD device-based procedures of testingApplication InsightsThere are numerous applications of the IVDs, which includes haematology, immunology, coagulation, clinical chemistry, molecular diagnostics and microbiology.
The home care market segment is anticipated to observe a lucrative progression owing to the persistent increase in the usage devices for point-of-care testing.
This analysis of the Global In-Vitro Diagnostics (IVD) Quality Control Market aims to offer relevant and well-researched insights into the contemporary market scenario and the emergent growth dynamics.
The report on In-Vitro Diagnostics (IVD) Quality Control Market also gives the market players and fresh contenders a holistic view of the global market landscape.
The comprehensive study will help both established and emerging players formulate lucrative business strategies and realize their short-term and long-term goals.The In-Vitro Diagnostics (IVD) Quality Control industry has witnessed a stable growth rate in the past decade and is expected to continue on the same path in the forthcoming decades.
Therefore, it is crucial to recognize all investment opportunities, potential market threats, restraining factors, challenges, market dynamics, and technological development to intensify footholds in the In-Vitro Diagnostics (IVD) Quality Control sector.
This report has evaluated all the above mentioned aspects to present a detailed assessment to the reader to assist them in achieving the desired growth in their businesses.Fill in your details to get your hands on an Exclusive Sample of this Report @ https://www.reportsanddata.com/sample-enquiry-form/1508Companies profiled for this market studyAgilent Diagnostics, Abbott Diagnostics, Becton, Dickson and Company, Bio-Rad Laboratories, Inc., and ThermoFisher ScientificFor the purpose of the study, this Reports and Data has segmented the Global In-Vitro Diagnostics (IVD) Quality Control Market on the basis of product type, manufacturer type, design, application, end user and the regional outlook:Product Type (Revenue, USD Million; 2016–2026)Quality ControlsWhole Blood-based ControlsSerum-based ControlsPlasma-based ControlsUrine-based ControlsOther IVD Quality ControlsData Management SolutionsQuality Assurance ServicesManufacturer Type (Revenue, USD Million; 2016–2026)Instrument Manufacturer ControlsIndependent Manufacturer ControlsThird-party ControlsInstrument Specific Manufacturer ControlsApplication (Revenue, USD Million; 2016–2026)Clinical ChemistryImmunochemistryHaematologyMolecular DiagnosticsCoagulation/HaemostasisMicrobiologyOthersEnd User (Revenue, USD Million; 2016–2026)HospitalsClinical LaboratoriesHome CareOthersClick here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/1508Table of Contents:Study Coverage: It includes key manufacturers covered, key market segments, the scope of products offered in the global In-Vitro Diagnostics (IVD) Quality Control market, duration considered, and objectives of the research.
Additionally, it segments the market on the basis of product type and application.Executive Summary: It offers a summary of other key studies, annual growth rate, competitive landscape, driving factors, market trends and issues, and macroscopic indicators.Production by Region: Here, the report delivers information related to import and export, production, revenue, and key players of all regional markets inspected in the report.Profile of Manufacturers: Each firm profiled in this segment is investigated by means of SWOT analysis, available products, global production, value, capacity, and other crucial factors.Highlights the following key factors:1) Business description-Detailed description of a firm’s operations and business segments.2) Corporate strategy – Analyst’s summarization of the company’s business strategy.3) SWOT Analysis – A detailed analysis of the company’s strengths, weaknesses, opportunities, and challenges.4) Company history – A company’s evolution, highlighting its key events through the years.5) Major products and services – A list of flagship products, services, and brands of the company.6) Key competitors – A list of key competitors of the company.7) Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.8) Detailed financial ratios for the past five years – The latest financial ratios derived from annual financial statements released by the company in the last five years.Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe growth of this market across the globe is dependent on multiple factors; including consumer base of several In-Vitro Diagnostics (IVD) Quality Control products, inorganic growth models adopted by companies, price volatility of feedstocks, and product innovation, along with their economic prospects in both producer and consumer nations.Overall, this report provides a clear view of every vital factor of the market without the need to refer to any other research reports or data sources.
Global In-Vitro Diagnostics (IVD) Quality Control Market Forecast to 2028 encompasses crucial data about the global In-Vitro Diagnostics (IVD) Quality Control market and includes a thorough examination of technological development, market drivers, market share, market size, and regional segmentation.
The report also provides a comprehensive evaluation of the market trends, vital statistical data, accurate market estimations, and the key suppliers and manufacturers of the In-Vitro Diagnostics (IVD) Quality Control market.The report is also attuned with the currently ongoing COVID-19 pandemic and its effect on the key segments of the market.
The report is updated with the impact of COVID-19 crisis, economic landscape, and present and future impact of COVID-19 on the market.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: Abbott Laboratories Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Randox Laboratories Ltd., Technopath Clinical Diagnostics, Fortress Diagnostics, Roche Diagnostics, Bio-Techne Corporation, Danaher Corporation, SeraCare Life Sciences Inc.The report also covers a comprehensive analysis of the strategic alliances such as mergers and acquisitions, joint ventures, partnerships, collaborations, agreements, government and corporate deals, and product launches and brand promotions.
The report also offers a thorough analysis of the product portfolios, production capacity, gross margins, revenues, and costing of the key manufacturers and vendors.
Furthermore, it also covers SWOT analysis and Porter’s Five Forces Analysis to offer a deeper insight into the competitive landscape of the market.By Product & Service Type (Revenue, USD Million; 2018-2028)Quality Control ProductsWhole Blood-based ControlsSerum/Plasma-based ControlsUrine-based ControlsData Management SolutionsQuality Assurance ServicesSource-based IVD Quality ControlsBy Manufacturer (Revenue, USD Million; 2018-2028)Third-Party Control ManufacturersOriginal Equipment Manufacturers (OEMs)Instrument-Specific ControlsIndependent ControlsBy Application (Revenue, USD Million; 2018-2028)Immunochemistry/ImmunoassayCoagulation & HemostasisMolecular DiagnosticsClinical ChemistryMicrobiologyHematologyOthersBy End-user (Revenue, USD Million; 2018-2028)HospitalsHome CareClinical LaboratoriesAcademic & Research InstitutesContract Research Organizations (CROs)IVD ManufacturersOthersBrowse Complete Report “In-Vitro Diagnostics (IVD) Quality Control Market” @ https://www.reportsanddata.com/report-detail/in-vitro-diagnostics-ivd-quality-control-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
